Anti-tumor activity of veliparib during combination phase with chemotherapy in velia study

S.M. O'Malley, Michael A Bookman, Kathleen N Moore, Gini F Fleming, Mark F Brady, Elizabeth M Swisher, Carol Aghajanian, Karina Dahl Steffensen, Michael Friedlander, Aikou Okamoto, N.M. Spirtos, M.S. Shahin, T.J. Reid, Danielle M Sullivan, V Sehgal, Peter J Ansell, Minh H Dinh, Robert L Coleman

Research output: Contribution to conference without publisher/journalConference abstract for conferenceResearchpeer-review

Abstract

Oral Abstract. LBA 9 – Late Breaking Abstract Session. Webinar #2: Paradigm Changes in Front Line Ovarian Cancer
Original languageEnglish
Publication date29. Apr 2020
Publication statusPublished - 29. Apr 2020
EventSGO Annual Meeting of Women's Cancer: Converted to webinar due to COVID-19 restrictions - Toronto, Canada
Duration: 28. Mar 202031. Mar 2020
https://www.sgo.org/education/annual-meeting-on-womens-cancer/

Conference

ConferenceSGO Annual Meeting of Women's Cancer
CountryCanada
CityToronto
Period28/03/202031/03/2020
Internet address

Fingerprint Dive into the research topics of 'Anti-tumor activity of veliparib during combination phase with chemotherapy in velia study'. Together they form a unique fingerprint.

Cite this